substance p has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganea, D; Gascón, P; Rameshwar, P | 1 |
| Chae, SL; Kim, JC; Lee, IG | 1 |
| Berthou, C; Bourquard, P; Eveillard, JR; Hardy, E; Ianotto, JC; Le Gall, C; Morice, P; Ngo-Sack, F; Ugo, V | 1 |
3 other study(ies) available for substance p and losartan potassium
| Article | Year |
|---|---|
In vitro stimulatory effect of substance P on hematopoiesis.
Topics: Antibodies, Monoclonal; Antigens, CD; Biphenyl Compounds; Blotting, Western; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Erythropoietin; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Interleukin-1; Interleukin-3; Interleukin-6; Kinetics; Monocytes; Recombinant Proteins; Substance P; Tumor Necrosis Factor-alpha | 1993 |
Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inducing Agents; Antigens, CD34; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelium, Vascular; Erythropoietin; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Retinal Neovascularization; Severity of Illness Index; Stem Cells; Substance P; Vascular Endothelial Growth Factor A | 2006 |
Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.
Topics: Cell Differentiation; Cell Proliferation; Cell Survival; Erythroid Precursor Cells; Erythropoietin; GTP-Binding Proteins; Humans; Peptide Fragments; Polycythemia Vera; Receptors, Tachykinin; RNA, Messenger; Substance P | 2008 |